Stroke (ischemic) - pathophysiology

Ischemic stroke pathophysiology involves a complex interplay of events following a disruption in cerebral blood flow, leading to an ischemic cascade that ultimately results in neuronal damage. Understanding the mechanisms of ischemia, including the ischemic penumbra, thrombosis/embolism, atherosclerosis, small vessel disease, cardioembolic stroke, hemodynamic stroke, inflammation, genetic predisposition, and reperfusion injury, is critical for effective diagnosis, treatment, and prevention.

Note 1: Defining Ischemic Stroke and Its Etiology Ischemic stroke, accounting for approximately 87% of all stroke cases, occurs when blood flow to the brain is interrupted, leading to oxygen and nutrient deprivation. This interruption is typically caused by a blockage within a blood vessel supplying the brain. The underlying etiology is often multifactorial, involving atherosclerosis (plaque buildup in arteries), thromboembolism (blood clot formation elsewhere in the body that travels to the brain), and small vessel disease (affecting smaller arteries deep within the brain). Less common causes include arterial dissection (tear in the artery wall), fibromuscular dysplasia (abnormal cell growth in artery walls), and certain hematological disorders that increase the risk of clotting. Understanding the specific cause is crucial for guiding treatment strategies and implementing preventative measures to reduce the risk of recurrent stroke. The location and size of the ischemic area determine the severity and specific neurological deficits observed in patients. Without prompt restoration of blood flow, irreversible brain damage can occur within minutes to hours.

Note 2: The Ischemic Cascade - A Detailed Look The ischemic cascade represents a complex sequence of biochemical and cellular events triggered by the sudden reduction or cessation of cerebral blood flow. Initially, ATP production is impaired due to lack of oxygen, leading to neuronal depolarization and release of excitatory neurotransmitters like glutamate. Excessive glutamate release causes excitotoxicity, where neurons are overstimulated, leading to an influx of calcium ions into the cells. This intracellular calcium overload activates various enzymes that degrade cell membranes, proteins, and DNA. Simultaneously, anaerobic metabolism results in lactic acid accumulation, contributing to intracellular acidosis and further neuronal damage. The disruption of the blood-brain barrier (BBB) allows inflammatory cells and molecules to enter the brain tissue, exacerbating the inflammatory response and contributing to edema formation. This cascade of events highlights the importance of early intervention to interrupt the damaging processes and salvage potentially viable brain tissue within the ischemic penumbra.

Note 3: The Ischemic Penumbra: A Region of Salvageable Tissue The ischemic penumbra is a critical concept in understanding ischemic stroke pathophysiology. It refers to the region of brain tissue surrounding the core infarct area (the area of irreversibly damaged tissue) that is at risk of infarction but still potentially salvageable. Neurons within the penumbra are functionally impaired due to reduced blood flow but are not yet irreversibly damaged. The degree of perfusion in the penumbra is insufficient to maintain normal neuronal function, but it is also not so low that rapid cell death is inevitable. The size and viability of the penumbra are influenced by factors such as collateral blood flow, the duration of ischemia, and individual patient characteristics. The therapeutic window for interventions like thrombolysis (clot-busting medication) and mechanical thrombectomy is based on the premise of rescuing the penumbra and preventing its progression to irreversible infarction. Imaging techniques like perfusion MRI and CT perfusion are used to identify and characterize the penumbra.

Note 4: Mechanisms of Thrombosis and Embolism Thrombosis, the formation of a blood clot within a blood vessel, and embolism, the dislodgement and migration of a clot to a distant site, are major contributors to ischemic stroke. Thrombosis in the cerebral arteries is often associated with atherosclerosis, where plaque rupture exposes thrombogenic substances that trigger clot formation. Emboli can originate from various sources, including the heart (cardioembolic stroke, e.g., atrial fibrillation), large arteries (atherothromboembolic stroke, e.g., carotid stenosis), or paradoxical embolism (clot from the venous system crossing to the arterial system through a patent foramen ovale). The composition of the clot can vary, influencing its susceptibility to thrombolysis. Red blood cell-rich clots tend to be more resistant to thrombolysis than platelet-rich clots. Understanding the source and composition of the clot is important for guiding treatment decisions and preventing future events.

Note 5: Atherosclerosis and its Role in Stroke Atherosclerosis, characterized by the buildup of plaque within arterial walls, is a leading cause of ischemic stroke. The process begins with endothelial dysfunction, followed by lipid deposition and inflammatory cell infiltration. Over time, the plaque can enlarge and narrow the arterial lumen, reducing blood flow. Plaque rupture or erosion can lead to thrombus formation, resulting in acute arterial occlusion. Risk factors for atherosclerosis include hypertension, hyperlipidemia, diabetes mellitus, smoking, and family history. The carotid arteries, which supply blood to the brain, are particularly vulnerable to atherosclerosis. Carotid stenosis (narrowing of the carotid artery) significantly increases the risk of stroke. Carotid endarterectomy (surgical removal of plaque) or carotid angioplasty with stenting may be performed to reduce the risk of stroke in patients with significant carotid stenosis.

Note 6: Small Vessel Disease (Lacunar Stroke) Small vessel disease, also known as lacunar disease, affects the small penetrating arteries deep within the brain. It is typically associated with chronic hypertension and diabetes mellitus. These conditions cause thickening and hardening of the arteriolar walls, leading to reduced blood flow and the formation of small infarcts (lacunes). Lacunar strokes often present with specific clinical syndromes, such as pure motor hemiparesis, pure sensory stroke, ataxic hemiparesis, and dysarthria-clumsy hand syndrome. The prognosis for lacunar strokes is generally better than for large vessel strokes, but they can still cause significant disability. Prevention strategies focus on controlling hypertension and diabetes mellitus.

Note 7: Cardioembolic Stroke and Atrial Fibrillation Cardioembolic stroke accounts for a significant proportion of ischemic strokes, with atrial fibrillation (AFib) being the most common underlying cause. AFib is characterized by irregular and rapid heartbeats, leading to blood stasis in the atria and an increased risk of thrombus formation. These thrombi can dislodge and travel to the brain, causing embolic stroke. Patients with AFib are typically treated with anticoagulants (e.g., warfarin, direct oral anticoagulants) to reduce the risk of stroke. The choice of anticoagulant depends on factors such as the patient's risk profile, renal function, and potential for drug interactions. Other cardiac conditions that can increase the risk of cardioembolic stroke include valvular heart disease, dilated cardiomyopathy, and infective endocarditis.

Note 8: Hemodynamic Stroke and Watershed Infarcts Hemodynamic stroke occurs due to a critical reduction in cerebral blood flow secondary to systemic hypoperfusion, rather than local arterial occlusion. This can result from severe hypotension (e.g., due to cardiac arrest, shock) or severe stenosis/occlusion of major arteries supplying the brain. Watershed infarcts are a characteristic feature of hemodynamic stroke. These infarcts occur in the border zones between the territories of different cerebral arteries (e.g., between the anterior cerebral artery (ACA) and middle cerebral artery (MCA), or between the MCA and posterior cerebral artery (PCA)). The border zone areas are particularly vulnerable to hypoperfusion because they receive the least blood supply. Management of hemodynamic stroke focuses on restoring adequate blood pressure and improving cerebral perfusion.

Note 9: The Role of Inflammation in Ischemic Stroke Inflammation plays a significant and complex role in the pathophysiology of ischemic stroke. While an initial inflammatory response is protective, promoting tissue repair and angiogenesis, an excessive and prolonged inflammatory response can exacerbate brain injury. Ischemia triggers the activation of microglia, the resident immune cells of the brain, as well as the infiltration of peripheral immune cells such as neutrophils and macrophages. These immune cells release inflammatory mediators, including cytokines and chemokines, which contribute to neuronal damage, edema formation, and blood-brain barrier disruption. Targeting the inflammatory response is a potential therapeutic strategy for ischemic stroke, but clinical trials have yielded mixed results. Further research is needed to better understand the timing and specific mechanisms of inflammation in stroke and to develop effective anti-inflammatory therapies.

Note 10: Genetic Predisposition and Stroke Risk While stroke is often attributed to modifiable risk factors like hypertension and smoking, genetic predisposition also plays a role in stroke risk. Certain genetic variations can increase susceptibility to atherosclerosis, hypertension, and other conditions that contribute to stroke. For example, variations in genes involved in lipid metabolism, coagulation, and inflammation have been associated with an increased risk of stroke. Specific genetic disorders, such as Fabry disease and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), can cause stroke through different mechanisms. Family history of stroke is an important risk factor to consider. Genetic testing may be indicated in certain cases, particularly in younger patients with a strong family history of stroke and no obvious modifiable risk factors.

Note 11: Reperfusion Injury: A Double-Edged Sword While restoring blood flow to the ischemic brain is crucial for salvaging tissue, reperfusion itself can paradoxically cause additional injury, known as reperfusion injury. This phenomenon is characterized by an exacerbated inflammatory response, increased oxidative stress, and further disruption of the blood-brain barrier. Upon reperfusion, oxygen free radicals are generated, leading to lipid peroxidation, protein damage, and DNA damage. The influx of inflammatory cells and mediators further contributes to tissue damage. Reperfusion injury can manifest as hemorrhagic transformation, where blood leaks into the infarcted tissue. Strategies to minimize reperfusion injury include limiting the duration of ischemia, optimizing blood pressure management during reperfusion, and potentially administering neuroprotective agents. Understanding the mechanisms of reperfusion injury is critical for optimizing stroke treatment and improving outcomes.

Note 12: Stroke Mimics and Differential Diagnosis It is essential to differentiate ischemic stroke from other conditions that can mimic its symptoms, often referred to as stroke mimics. Common stroke mimics include migraine with aura, seizures with postictal paralysis (Todd's paralysis), brain tumors, multiple sclerosis exacerbations, and metabolic encephalopathies (e.g., hypoglycemia, hyponatremia). Accurate diagnosis is crucial because the treatment for stroke differs significantly from the treatment for these other conditions. Neuroimaging, such as CT or MRI, is essential to rule out hemorrhage and other structural abnormalities. A thorough neurological examination and medical history are also critical. The use of validated stroke scales, such as the National Institutes of Health Stroke Scale (NIHSS), can help to quantify neurological deficits and differentiate stroke from other conditions.

Browse public study notes